Skip to main content

Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Closure After Total Shoulder Arthroplasty: Prineo vs Dermabond

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat

Virtual Colonoscopy Using Omnipaque as a Contrast Agent

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Virtual Colonoscopy Using Omnipaque as a Contrast Agent

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • Page 229
  • Page 230
  • …
  • Next page Next
  • Last page Last
Subscribe to